Gilead climbs as coronavirus drug shows efficacy, starts trial

Gilead climbs as coronavirus drug shows efficacy, starts trial

Source: 
Fierce Biotech
snippet: 

Gilead has made progress in its effort to reposition failed Ebola drug remdesivir as a treatment for the coronavirus sweeping across China. In quick succession, it emerged that the nucleotide analogue prodrug appeared to help the first U.S. case of the virus and is set to undergo clinical testing in China, sending Gilead’s stock up by as much as 13% in premarket trading.